FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2071304375> ?p ?o ?g. }

• W2071304375 endingPage "1242" @default.
• W2071304375 startingPage "1229" @default.
• W2071304375 abstract "Preserving the chemical and structural integrity of therapeutic antibodies during manufacturing and storage is a major challenge during pharmaceutical development. Oxidation of Fc methionines Met252 and Met428 is frequently observed, which leads to reduced affinity to FcRn and faster plasma clearance if present at high levels. Because oxidation occurs in both positions simultaneously, their individual contribution to the concomitant changes in pharmacokinetic properties has not been clearly established. A novel pH-gradient FcRn affinity chromatography method was applied to isolate three antibody oxidation variants from an oxidized IgG1 preparation based on their FcRn binding properties. Physico-chemical characterization revealed that the three oxidation variants differed predominantly in the number of oxMet252 per IgG (0, 1, or 2), but not significantly in the content of oxMet428. Corresponding to the increase in oxMet252 content, stepwise reduction of FcRn affinity in vitro, as well as faster clearance and shorter terminal half-life, in huFcRn-transgenic mice were observed. A single Met252 oxidation per antibody had no significant effect on pharmacokinetics (PK) compared with unmodified IgG. Importantly, only molecules with both heavy chains oxidized at Met252 exhibited significantly faster clearance. In contrast, Met428 oxidation had no apparent negative effect on PK and even led to somewhat improved FcRn binding and slower clearance. This minor effect, however, seemed to be abrogated by the dominant effect of Met252 oxidation. The novel approach of functional chromatographic separation of IgG oxidation variants followed by physico-chemical and biological characterization has yielded the first experimentally-backed explanation for the unaltered PK properties of antibody preparations containing relatively high Met252 and Met428 oxidation levels." @default.
• W2071304375 created "2016-06-24" @default.
• W2071304375 creator A5013013933 @default.
• W2071304375 creator A5014231189 @default.
• W2071304375 creator A5016075040 @default.
• W2071304375 creator A5024497834 @default.
• W2071304375 creator A5029298052 @default.
• W2071304375 creator A5036328889 @default.
• W2071304375 creator A5053322155 @default.
• W2071304375 creator A5056086517 @default.
• W2071304375 creator A5056936694 @default.
• W2071304375 creator A5066536364 @default.
• W2071304375 creator A5073858735 @default.
• W2071304375 creator A5077774394 @default.
• W2071304375 creator A5083451409 @default.
• W2071304375 creator A5091501524 @default.
• W2071304375 date "2014-09-03" @default.
• W2071304375 modified "2023-10-13" @default.
• W2071304375 title "A novel approach to investigate the effect of methionine oxidation on pharmacokinetic properties of therapeutic antibodies" @default.
• W2071304375 cites W1483007604 @default.
• W2071304375 cites W1519854173 @default.
• W2071304375 cites W1520693665 @default.
• W2071304375 cites W1686249017 @default.
• W2071304375 cites W1944996883 @default.
• W2071304375 cites W1968135923 @default.
• W2071304375 cites W1969720279 @default.
• W2071304375 cites W1971242419 @default.
• W2071304375 cites W1972018125 @default.
• W2071304375 cites W1977030960 @default.
• W2071304375 cites W1977437955 @default.
• W2071304375 cites W1977937625 @default.
• W2071304375 cites W1979162895 @default.
• W2071304375 cites W1979626824 @default.
• W2071304375 cites W1979765476 @default.
• W2071304375 cites W1983227662 @default.
• W2071304375 cites W1987213198 @default.
• W2071304375 cites W1995923662 @default.
• W2071304375 cites W2004608667 @default.
• W2071304375 cites W2014004623 @default.
• W2071304375 cites W2030877506 @default.
• W2071304375 cites W2043085127 @default.
• W2071304375 cites W2043920247 @default.
• W2071304375 cites W2048504768 @default.
• W2071304375 cites W2054915531 @default.
• W2071304375 cites W2060365579 @default.
• W2071304375 cites W2065303540 @default.
• W2071304375 cites W2071150425 @default.
• W2071304375 cites W2071425823 @default.
• W2071304375 cites W2071843728 @default.
• W2071304375 cites W2072546632 @default.
• W2071304375 cites W2075901113 @default.
• W2071304375 cites W2078111332 @default.
• W2071304375 cites W2081641593 @default.
• W2071304375 cites W208585742 @default.
• W2071304375 cites W2090618368 @default.
• W2071304375 cites W2092638671 @default.
• W2071304375 cites W2103735104 @default.
• W2071304375 cites W2105827674 @default.
• W2071304375 cites W2110903116 @default.
• W2071304375 cites W2119562248 @default.
• W2071304375 cites W2146963696 @default.
• W2071304375 cites W2168236041 @default.
• W2071304375 cites W2169160438 @default.
• W2071304375 cites W2400008297 @default.
• W2071304375 cites W2402018854 @default.
• W2071304375 cites W2485000142 @default.
• W2071304375 cites W4247579063 @default.
• W2071304375 doi "https://doi.org/10.4161/mabs.29601" @default.
• W2071304375 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4622569" @default.
• W2071304375 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25517308" @default.
• W2071304375 hasPublicationYear "2014" @default.
• W2071304375 type Work @default.
• W2071304375 sameAs 2071304375 @default.
• W2071304375 citedByCount "87" @default.
• W2071304375 countsByYear W20713043752015 @default.
• W2071304375 countsByYear W20713043752016 @default.
• W2071304375 countsByYear W20713043752017 @default.
• W2071304375 countsByYear W20713043752018 @default.
• W2071304375 countsByYear W20713043752019 @default.
• W2071304375 countsByYear W20713043752020 @default.
• W2071304375 countsByYear W20713043752021 @default.
• W2071304375 countsByYear W20713043752022 @default.
• W2071304375 countsByYear W20713043752023 @default.
• W2071304375 crossrefType "journal-article" @default.
• W2071304375 hasAuthorship W2071304375A5013013933 @default.
• W2071304375 hasAuthorship W2071304375A5014231189 @default.
• W2071304375 hasAuthorship W2071304375A5016075040 @default.
• W2071304375 hasAuthorship W2071304375A5024497834 @default.
• W2071304375 hasAuthorship W2071304375A5029298052 @default.
• W2071304375 hasAuthorship W2071304375A5036328889 @default.
• W2071304375 hasAuthorship W2071304375A5053322155 @default.
• W2071304375 hasAuthorship W2071304375A5056086517 @default.
• W2071304375 hasAuthorship W2071304375A5056936694 @default.
• W2071304375 hasAuthorship W2071304375A5066536364 @default.
• W2071304375 hasAuthorship W2071304375A5073858735 @default.
• W2071304375 hasAuthorship W2071304375A5077774394 @default.
• W2071304375 hasAuthorship W2071304375A5083451409 @default.
• W2071304375 hasAuthorship W2071304375A5091501524 @default.

• next